IDENTIFICATION

OF Ad4BP/SF-1
Since the genes of the steroidogenic P450s were cloned and characterized in the 1980s, major efforts of several laboratories have been directed to defining the regulatory mechanism of the genes in animal tissues, and a variety of cis-elements have been identified in the gene promoters (7, 8 ). An element named Ad4 (adrenal 4) (9) or SF-i (steroidogenic factor-i) (10) has attracted particular attention since the site was found to be implicated in the steroidogenic tissue-specific regulation of the GYP genes. Moreover, the site was found in all the steroidogenic GYP gene promoters.
Morohashi and collaborators (ii) purified a nuclear protein factor binding to the Ad4 site from bovine adrenal cortex and designated it Ad4BP. Based on the amino acid sequences of the peptidesderived from the purified Ad4BP by protease digestion, its cDNA was isolated and characterized (12). Parker and collaborators (7) also isolated the corresponding cDNA, which they designated SF-i, from mice by using H-2RIIBP cDNA as the probe because the binding sequence of the factor contained a half unit (AGGTCA) of the nucleotide sequence recognized by the members of the steroid hormone receptor superfamily (13 
TISSUE-SPECIFIC EXPRESSION OF Ad4BP/ SF-i
The unique distribution of Ad4BP/SF-1 among animal tissues is another feature of the transcription factor to be described.
The expression of Ad4BP/SF-i in the adrenal cortex, testis, and ovary was first confirmed by Northern and Western blot analyses. Further analyses with RT-PCR revealed that the transcription factor is also expressed in other steroidogenic tissues like placenta and adipose tissue (12). Because those steroidogenic tissues consist of several cell types, the Ad4BP/SF-i expressing cells were examined by immunohistochemistry (18) and by in situ hybridization (19). In the adrenal gland, the cells constituting all three zones of the adrenal cortex were positive but the cells of the adrenal medulla were negative. In the gonads, Sertoli and Leydig cells in the testis, as well grailulosa, theca, and corpus luteum cells in the ovary, were positive.
The distribution of Ad4BP/SF-i in these cells indicated that the transcription factor is expressed in the cells where at least one steroidogenic P450 is expressed. In fact, when the expression of the steroidogenic P450s in the cycling human ovaries was investigated, the expression in the granulosacellscoincided with the expressionprofile Of Ad4BP/SF-i. The granulosacellsinatretic follicles that do not express the steroidogenicP450s were negativefor the Ad4BP/SF-i expression (20). It was reported that Sertolicellssynthesizethe estrogenduring a restricted short period from prenatal to postnatal although the activity disappears in the adult tissue thereafter (21). The GYP19 gene coding for aromatase P450, which is essential for estrogen synthesis, is likely to be regulated by Ad4BP/SF-1 in the Sertoli cells during the restricted period as in the ovarian granulosa cells (22, 23). However, some unknown genes could be the target of the transcription factor in the Sertolicellsof the mature testes.Itis also expected that a wide variety of genes other than the GYP genes are governed by Ad4BP/SF-i in the steroidogenic cell types in addition to the Sertoli cells. Actually the oxytocin gene expressed in the corpus luteum was the first gene other than the steroidogenicGYP genes reportedto be regulated by Ad4BP/SF-1 (24) ( Table  1) . Several other genes including the inhibin a-and 3-B-subunit genes (25), the luteinizing hormone receptor gene (26), and the StAR (steroidogenic acute regulatoryprotein)gene (27) expressed in the steroidogeniccellshave an Ad4/SF-1 sitesin their upstream regionsalthough the contributionof the sitesto the gene expressions remains to be confirmed. The RT-PCR study performed with variousmammalian tissuesunexpectedly revealed that the pituitaryand hypothalamus, the nonsteroidogenic tissues, also expressed Ad4BP/SF-i (12).The pituitaryconsistsof fivedistinct types of trophs, somatotoroph, corticotroph, thyrotroph, gonadotroph, and lactotoroph, which synthesize different tropic peptide hormones.
Because the Ad4BP/SF-1-positive cells are restricted to a certain cell population in the pituitary, the celltype was determined by detecting the peptide hormone synthesizedin the positive cells. As the result,the distribution of the gonadotropin synthesizing cells were clearly consistent with those of the Ad4BP/SF-1 positive nuclei (5, 28). In the hypothalamus, a ventromedial hypothalamic nucleus (VMH) is the only positive cell population as examined with serial sections of the tissue (5, 28). As these positive cells in the pituitary and the VMH do not express the steroidogenic P450s, the target genes of the Ad4BP/SF-1 seem to be other genes. According to the study by Barnhart and Mellon (29) , the glycoprotein hormone a-subunit gene is one of the candidate genes in the gonadotroph.
In fact, their previous study indicated that the glycoprotein hormone a-subunit gene is regulated by a gonadotroph-specific element identical to Ad4/SF-i sequence and a binding protein factor whose molecular weight is quite similar to Ad4BP/SF-i (30). It is likely that the gonadotroph-specific element binding protein they identified independently was Ad4BP/SF-i. Therefore,as in the steroidogenictissues, Ad4BP/SF-1 is possibly essential for the gonadotroph-specific function by regulating the troph-specific genes. In fact, this notion was the adrenal gland and the gonads completely disappeared from the gene-disrupted mice as shown in Fig. 1 (4-6) . Because Ad4BP/SF-1 is the key factor for the steroidogenic GYP gene transcription as described above, transcription of the GYP genes should be severely affected in the gene-disrupted mice. However, it is unlikely that the developmental defects observed with the adrenal gland and gonads were caused by the absence of the steroidogenic P450s. The defect was already detectable in mouse fetuses at 11.5 days postcoitum (d.p.c.), before the onset of the GYP gene transcription.
mFtz-F1
GENE-DISRUPTED MOUSE
The agenesis of the adrenal gland and gonads in the gene-disrupted mice suggested that Ad4BP/SF-i is involved in the regulation of some genes that are crucial for the differentiation of those tissues in the early stages of the embryonic development.
The effects of the disruptionof the mFtz-F1 gene on the pituitary gonadotrophs and the VMH seemed to be different from those on the peripheral tissues. In the pituitary of the gene-disrupted mice, all the trophs except the gonadotrophs functioned normally judging from the immunoreactivities of the peptide hormones. Gyp genes are also indicated.
1-positive cells (ratfetusesof 13.5 d.p.c.or mouse fetuses of the corresponding age) (Fig. 2) . Thereafter,the cell population developed into the adrenal gland in the pentoneal cavity. Immunoblot analyses indicated that the expression of Ad4BP/SF-1 continued at a high level after the onset of the adrenal development throughout the animal life (34).
On the contrary, the expression profile of Ad4BP/SF-1 in the gonads is different from that in the adrenal cortex. The most prominent difference is the sexually dimorphic expression, which was not observed in the adrenal gland (Fig. 3) . In the mouse fetuses, sex dependent differentiation of the gonads starts at 11.5-12.5 d.p.c.. Differentiation into the testis is known to be induced by the expression of the sex-determining region on Y chromosome (SRY) (35) whose expression is restricted to a narrow window, with a peak at 11.5 d.p.c. of the male gonad (36). Differentiation of testicular cords and tunica albuminea is obvious in the male genital ridge, whereas such differentiation is not seen in the female. (Fig. 3) . The expression of the MIS gene starts in the male genital ridge at around 11.5 d.p.c. (36) and starts in the female ovarian follicles after birth (39). The steroidogenic GYP genes are also transcribed after the onset of the Ad4BP/SF-i expression. Considering the fact that the prior expression of transcription factors are needed for the onset of the transcription of the target genes, the expression profiles of these genes and Ad4BP/SF-1 were as expected.
Consistent expressions of Ad4BP/SF-i and its putative target genes were also observed during ovarian ?.
Ad4BPiSF'
TRANSCRIPTION FACTOR Ad4BP/SF-1 1575 folliculogenesis and luteinization (20) . Hwever, the expression of the target genes are not fully explained by Ad4BP/SF-i.
Despite the sustained expression of Ad4BP/ SF-i in Sertoli cells of the mature testes, MISMIS gene expression disappeared before testis maturation, indicating that some additional stimulation is necessary to maintain the MIS gene transcription.
In other words, Ad4BP/ SF-i does not explain all the transcriptional regulations in the steroidogenic tissues, although it is surely an indispensable factor.
REGULATORY MECHANISM
OF THE mFtz-F1
GENE
To gain deeper insight into the role of Ad4BP/SF-i in adrenal and gonadal differentiation, information about the downstream genes of Ad4BP/SF-1 and the regulation of the mFtz-F1 gene transcription during differentiation of the tissues is essential.
As described, information about the downstream genes is gradually increasing, but the genes identified so far are not enough to explain the fundamental function of Ad4BP/SF-i in the tissue differentiation.
Further investigations will clarify the wider function of Ad4BP/SF-1 through enumeration of the downstream genes.
The mFtz-F1 gene was cloned from mice (19, 40) 
-Fi
gene by the transfection of the CAT gene constructs into the cultured cells and demonstrated that an E box present immediately upstream from the transcription initiation site is necessary for the gene transcription. They also found that the first intron of the mFtz-F1 gene contained a transcriptional element that significantly enhanced the activity driven by the E box (42). Further analyses of the first intron by introduction of a series of deletions or nucleotide substitutions showed that Ad4/SF-1 is the element in the first intron. Binding of Ad4BP/SFito the element was confirmed by inhibition of the binding by the antibody to Ad4BP/SF-i with the gel shift analysis. These observations indicated that the mFtz-Fi gene is controlled by a unique regulatory mechanism in which the gene product, Ad4BP/SF-i, plays an essential role in the gene transcription (Fig. 4) . Such an autoregulatory mechanism has been reported to function in some other genes including the Hox4.2 (43), MyoDi
and Pit-i (45) genes, all of which are known to play significant roles in the differentiation of certain tissues or cell types. When a differentiation process of a tissue is considered, it is reasonable to assume the function of a gene regulatory cascade in which certain genes encoding transcription fac- torsare involved as the components.
In the cascades required for adrenal and gonadal differentiation, Ad4BP/ SF-i is located upstream of some tissue-specific genes, including the steroidogenic GYP genes, and located downstream of some other genes regulating the mFtz-Fi gene transcription.
As shown in Fig. 5 , once the cells differentiate into particular cell types and the differentiated state is to be maintained thereafter, the tissue-specific transcription factor described above will need to remain transcribed in the cell types. It is possible that the autoregulation is one of the mechanisms to maintain the genes in the transcribable state. Another possible benefit of the autoregulation is that the upstream genes essential for the initial onset of the gene transcription are no longer needed to maintain the gene regulatory cascade. 
